Offerings (SEC Form D)
Each filing as reported by the issuer, newest first. Open a row for the full plain-English detail. D = original notice, D/A = amendment.
Mar 21, 2017 D Biotechnology — $7,221,001 sold of $7,221,001 · 1 investors EDGAR ↗
| Filing | Form D filed Mar 21, 2017SEC file no. 021-283016 · accession 0001140361-17-012842 |
| Raise progress | $7,221,001 sold of $7,221,001 offered (100%) · $0 remaining · first sale Mar 14, 2017 |
| Filing timing | Date of first sale: Mar 14, 2017 · Form D filed: Mar 21, 2017 (7 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 3,511 days (9.6 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 1 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 as filed (no minimum reported) |
| Securities offered | Equity |
| Entity details | Organized in DELAWARE · formed 2014 · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Biotechnology |
| Who is paid to sell it | H.C. Wainwright & Co., LLC — FINRA BrokerCheck CRD 375 ↗ Solicits in: IL, NY |
| Money to insiders | Sales commissions: $505,470 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Lan Huang, Chief Executive Officer (Mar 21, 2017) |
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$50,000. Offering size: $7,221,001. Typical range: $2,000,000–$19,999,994. Investors: 1. Typical range: 2–16."Similar" = Biotechnology, Rule 506(b). Based on 3,253 Form D filings 2021–2026 in the same industry and exemption (Biotechnology, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 704, offering size 3,078, investors 3,148. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
All Form D filings for this CIK on SEC EDGAR ↗. History: 0 new offerings in the last 12 months (new offering = a Form D that is not an amendment) · most recent filing Mar 21, 2017. Industry as reported, by offering: One offering, reported as Biotechnology (Mar 21, 2017).
Key people 11
Officers, directors and promoters the issuer itself named on its Form D. Tap a name for every other deal they are on.
| Name | Relationship | Address state | On filings (first → last) | Also listed on |
|---|
| CZ Christine Y. Zhao | Director | NY | Mar 21, 2017 on 1 of 1 filing listed on the latest filing | — |
| GL G. Kenneth Lloyd | Executive Officer | NY | Mar 21, 2017 on 1 of 1 filing listed on the latest filing | — |
| GS Gordon L. Schooley | Executive Officer | NY | Mar 21, 2017 on 1 of 1 filing listed on the latest filing | — |
| LH Lan Huang | Executive Officer, Director | NY | Mar 21, 2017 on 1 of 1 filing listed on the latest filing | — |
| MK Matthew Kirkby | Director | NY | Mar 21, 2017 on 1 of 1 filing listed on the latest filing | — |
| ML Mulong Liu | Director | NY | Mar 21, 2017 on 1 of 1 filing listed on the latest filing | — |
| NH Nanxing He | Director | NY | Mar 21, 2017 on 1 of 1 filing listed on the latest filing | — |
| QS Quanqi Song | Director | NY | Mar 21, 2017 on 1 of 1 filing listed on the latest filing | — |
| RM Ramon Mohanlal | Executive Officer | NY | Mar 21, 2017 on 1 of 1 filing listed on the latest filing | — |
| RB Richard A. Brand | Executive Officer | NY | Mar 21, 2017 on 1 of 1 filing listed on the latest filing | 1 other issuer |
| YX Yanbin Xie | Director | NY | Mar 21, 2017 on 1 of 1 filing listed on the latest filing | — |
Executive officers, directors and promoters as self-reported by the issuer, one row per person. Spellings of the same name (same first and last name, or the same full name that EDGAR split differently into middle and last name) with no conflicting middle initial are shown on one row (none on this issuer); dates and counts come from the filings that list each name. Licensed persons: FINRA BrokerCheck ↗ · SEC IAPD ↗. Middle names: the SEC Form D data set (RELATEDPERSONS.tsv) repeats the previous person's middle name into later rows of the same filing; where that happened PartnerFacts shows the name without the repeated middle name and keeps the data-set spelling on record (Ramon Kenneth Mohanlal) — the filing on EDGAR is the source.
Connections
Other issuers listing the same people:
Shared address: this business address appears on no other issuer's filings in our index. As of Oct 23, 2026, 5:45 PM ET.
Other offering types (Regulation A and Regulation Crowdfunding)
Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.
Adviser registration (Form ADV)
Searched SEC Form ADV bulk data (registered + exempt reporting advisers) (24,962 records as of Oct 2, 2026, 8:00 AM ET) — nothing matched BeyondSpring Inc..
Meta advertising
No Meta Pixel ids or Facebook / Instagram page links on file for BeyondSpring Inc. as of Oct 24, 2026 — the sponsor website is read for them once it is on file (runs automatically). Meta Ad Library: not searched by PartnerFacts (no API access); a one-tap Ad Library search is under Look further.
Public profiles
Public profiles official links and public statements, each with its source and date
No website or social profile named in BeyondSpring Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #274,982 of 374,652 in line (14 issuers searched so far).
Sources searched for a website: Form C data set (issuer websites as filed), Form ADV data set (Item 1.I of matched advisers) — as of Oct 23, 2026, 11:20 PM ET: none on file for this issuer. The sponsor website, the Internet Archive and GDELT news index are read only once a site is on file; a sponsor's website comes from the issuer's own filings (Form C issuer website; EDGAR company profile), an approved profile claim, Form ADV Item 1.I of its matched adviser, or a web search for the issuer name confirmed on the site's own homepage. We never collect personal or family accounts.
Entity standing: not checked (no official programmatic source for NY yet).
Export this report as PDF (all source links + data timestamp) · Premium
Request diligence pack (Premium) PartnerFacts asks the sponsor for the standard information pack and delivers it to you labelled "provided by the sponsor".
Corrections log
No corrections have been requested for this page.
Filing-to-filing changes are in Amendment history above.
Email me the full report
The complete public-record profile for BeyondSpring Inc., plus the weekly new-filings list.
What do you want to do?
Only "Connect me" shares your details — with this sponsor, at a flat price we charge them, never tied to whether you invest. "Just researching" shares nothing.
Request a correction
Free. Tell us what's wrong and, if you can, where the correct public record is. Every request is logged with its status (received → under review → fixed / confirmed with source).